Design of novel nicotinamides as potent and selective monoamine oxidase a inhibitors

Bioorg Med Chem. 2010 Feb 15;18(4):1659-64. doi: 10.1016/j.bmc.2009.12.065. Epub 2010 Jan 4.

Abstract

A series of N-(2-morpholinoethyl)nicotinamide (1-13) and N-(3-morpholinopropyl)nicotinamide derivatives (14-26) have been designed, synthesized and evaluated in vitro for their monoamine oxidase (MAO) A and B inhibitory activity and selectivity. Most of these synthesized compounds proved to be potent, and selective inhibitors of MAO-A rather than of MAO-B. 5-Chloro-6-hydroxy-N-(2-morpholinoethyl)nicotinamide (13) displayed the highest MAO-A inhibitory potency (IC(50)=0.045 microM) and a good selectivity. 2-Bromo-N-(2-morpholinoethyl)nicotinamide (3) was the most potent MAO-B inhibitor with the IC(50) value of 0.32 microM, but it was not selective. Molecular dockings of compound 13 were performed in order to give structural insights regarding the MAO-A selectivity.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Brain / drug effects
  • Brain / enzymology
  • Magnetic Resonance Spectroscopy
  • Mitochondria / drug effects
  • Mitochondria / enzymology
  • Models, Molecular
  • Monoamine Oxidase / drug effects*
  • Monoamine Oxidase Inhibitors / chemistry*
  • Monoamine Oxidase Inhibitors / pharmacology*
  • Niacinamide / chemistry*
  • Niacinamide / pharmacology*
  • Rats
  • Spectrometry, Mass, Electrospray Ionization
  • Structure-Activity Relationship

Substances

  • Monoamine Oxidase Inhibitors
  • Niacinamide
  • Monoamine Oxidase